Case report describes a rare inflammatory rhabdomyoblastic tumour, highlighting its classification and malignancy.
Background: Inflammatory rhabdomyoblastic tumour (IRMT) is the new consensus terminology in the upcoming 6 th edition of the World Health Organization Classification of Tumours, 1 replacing the previously described entity “inflammatory leiomyosarcoma”. It is a very rare and the only known skeletal muscle tumour of borderline malignancy with less than 50 cases reported in the literature. 1,2
No takes yet. Share an insight, caveat, or question.
Jia et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: